Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 45
Filter
1.
Neoplasia ; 37: 100885, 2023 03.
Article in English | MEDLINE | ID: mdl-36764090

ABSTRACT

BACKGROUND: Myxoid glioneuronal tumor (MGT) is a benign glioneuronal neoplasm recently introduced in the World Health Organization (WHO) classification of the central nervous system (CNS) tumors. MGTs are typically located in the septum pellucidum, foramen of Monro or periventricular white matter of the lateral ventricle. They were previously diagnosed as dysembryoplastic neuroepithelial tumors (DNT), showing histological features almost indistinguishable from classical cortical DNT. Despite that, MGTs have been associated with a specific dinucleotide substitution at codon 385 in the platelet-derived growth factor receptor alpha (PDGFRA) gene, replacing a lysine residue with either leucine or isoleucine (p. LysK385Leu/Iso). This genetic variation has never been described in any other CNS tumor. MATERIALS AND METHODS: Thirty-one consecutive tumors, previously diagnosed as DNTs at the Meyer Children's Hospital IRCCS between January 2010 and June 2021 were collected for a comprehensive study of their clinical, imaging, pathological features, and molecular profile. RESULTS: In six out of the thirty-one tumors we had previously diagnosed as DNTs, we identified the recurrent dinucleotide mutation in the PDGFRA. All six tumors were typically located within the periventricular white matter of the lateral ventricle and in the septum pellucidum. We then renamed these lesions as MGT, according to the latest WHO CNS classification. In all patients we observed an indolent clinical course, without recurrence. CONCLUSION: MGT represent a rare but distinct group of neoplasm with a typical molecular profiling, a characteristic localization, and a relative indolent clinical course.


Subject(s)
Brain Neoplasms , Child , Humans , Brain Neoplasms/pathology , Magnetic Resonance Imaging , Septum Pellucidum/pathology , Mutation , Receptor Protein-Tyrosine Kinases/genetics , Disease Progression
2.
AJNR Am J Neuroradiol ; 40(12): 2137-2142, 2019 12.
Article in English | MEDLINE | ID: mdl-31727747

ABSTRACT

BACKGROUND AND PURPOSE: Conventional MR imaging has limitations in detecting focal cortical dysplasia. We assessed the added value of 7T in patients with histologically proved focal cortical dysplasia to highlight correlations between neuropathology and ultra-high-field imaging. MATERIALS AND METHODS: Between 2013 and 2019, we performed a standardized 7T MR imaging protocol in patients with drug-resistant focal epilepsy. We focused on 12 patients in whom postsurgical histopathology revealed focal cortical dysplasia and explored the diagnostic yield of preoperative 7T versus 1.5/3T MR imaging and the correlations of imaging findings with histopathology. We also assessed the relationship between epilepsy surgery outcome and the completeness of surgical removal of the MR imaging-visible structural abnormality. RESULTS: We observed clear abnormalities in 10/12 patients using 7T versus 9/12 revealed by 1.5/3T MR imaging. In patients with focal cortical dysplasia I, 7T MR imaging did not disclose morphologic abnormalities (n = 0/2). In patients with focal cortical dysplasia II, 7T uncovered morphologic signs that were not visible on clinical imaging in 1 patient with focal cortical dysplasia IIa (n = 1/4) and in all those with focal cortical dysplasia IIb (n = 6/6). T2*WI provided the highest added value, disclosing a peculiar intracortical hypointense band (black line) in 5/6 patients with focal cortical dysplasia IIb. The complete removal of the black line was associated with good postsurgical outcome (n = 4/5), while its incomplete removal yielded unsatisfactory results (n = 1/5). CONCLUSIONS: The high sensitivity of 7T T2*-weighted images provides an additional tool in defining potential morphologic markers of high epileptogenicity within the dysplastic tissue of focal cortical dysplasia IIb and will likely help to more precisely plan epilepsy surgery and explain surgical failures.


Subject(s)
Magnetic Resonance Imaging/methods , Malformations of Cortical Development/diagnostic imaging , Neuroimaging/methods , Adolescent , Adult , Drug Resistant Epilepsy/etiology , Drug Resistant Epilepsy/surgery , Female , Humans , Male , Malformations of Cortical Development/complications , Middle Aged
4.
Breast Cancer Res Treat ; 170(3): 445-454, 2018 Aug.
Article in English | MEDLINE | ID: mdl-29616377

ABSTRACT

PURPOSE: Secretory breast cancer (SBC) is one of the rarest breast cancer (BC), representing the majority of BC in childhood. Nevertheless, it elicits a lot of interest both for the peculiar morphology and the characteristic genetic features. Currently, there is no consensus on optimal treatment strategy. Therefore, it is useful to report every case in order to establish treatment algorithms. METHODS: We describe the case of a 6-year-old boy diagnosed with a SBC, with peculiar genomic and immunohistochemical features. Moreover, we carried out a review of the literature in order to analyze the present state of knowledge about this rare entity. RESULTS: To the best of our knowledge, there are only 120 cases published in literature, only 32 in males and only 2 younger than 6 years. Furthermore, this one had peculiar genomic and immunohistochemical features. Indeed, even if SBC expresses basal-cell markers, our patient had a triple-negative tumor expressing both basal and luminal cell markers. Furthermore, the boy's genomic profile revealed not only positivity for the typical SBC's translocation t(12;15), but also for a 3q28 duplication, found in his father (healthy) and paternal grandfather (with a previous BC). None were positive for BRCA mutation. This locus includes only one gene encoding for a growth factor recently linked to Early Infantile Epileptic Encephalopathy-47 and Idiopathic ventricular tachycardia. Even if the literature does not provide evidence of a pathogenic role it is not possible to exclude a cancer-predisposing activity. CONCLUSIONS: SBC is a rare type of BC, characterized by triple-negative features with an unexpectedly good prognosis. More data are needed to fully understand the behavior of this cancer and genomic profiling could be helpful in improving its diagnosis and management.


Subject(s)
Biomarkers, Tumor , Breast Neoplasms, Male/diagnosis , Breast Neoplasms, Male/genetics , Breast Neoplasms/diagnosis , Breast Neoplasms/genetics , Carcinoma/diagnosis , Carcinoma/genetics , Gene Duplication , Biomarkers , Breast Neoplasms/metabolism , Breast Neoplasms, Male/metabolism , Carcinoma/metabolism , Child , Follow-Up Studies , Humans , Male , Tumor Burden , Ultrasonography
5.
Glia ; 64(6): 1066-82, 2016 Jun.
Article in English | MEDLINE | ID: mdl-27014996

ABSTRACT

Tuberous sclerosis complex (TSC) is a genetic disease presenting with multiple neurological symptoms including epilepsy, mental retardation, and autism. Abnormal activation of various inflammatory pathways has been observed in astrocytes in brain lesions associated with TSC. Increasing evidence supports the involvement of microRNAs in the regulation of astrocyte-mediated inflammatory response. To study the role of inflammation-related microRNAs in TSC, we employed real-time PCR and in situ hybridization to characterize the expression of miR21, miR146a, and miR155 in TSC lesions (cortical tubers and subependymal giant cell astrocytomas, SEGAs). We observed an increased expression of miR21, miR146a, and miR155 in TSC tubers compared with control and perituberal brain tissue. Expression was localized in dysmorphic neurons, giant cells, and reactive astrocytes and positively correlated with IL-1ß expression. In addition, cultured human astrocytes and SEGA-derived cell cultures were used to study the regulation of the expression of these miRNAs in response to the proinflammatory cytokine IL-1ß and to evaluate the effects of overexpression or knockdown of miR21, miR146a, and miR155 on inflammatory signaling. IL-1ß stimulation of cultured glial cells strongly induced intracellular miR21, miR146a, and miR155 expression, as well as miR146a extracellular release. IL-1ß signaling was differentially modulated by overexpression of miR155 or miR146a, which resulted in pro- or anti-inflammatory effects, respectively. This study provides supportive evidence that inflammation-related microRNAs play a role in TSC. In particular, miR146a and miR155 appear to be key players in the regulation of astrocyte-mediated inflammatory response, with miR146a as most interesting anti-inflammatory therapeutic candidate.


Subject(s)
Astrocytes/metabolism , Astrocytoma/metabolism , MicroRNAs/metabolism , Tuberous Sclerosis/metabolism , Adolescent , Adult , Astrocytoma/pathology , Brain/metabolism , Cell Culture Techniques , Cells, Cultured , Child , Child, Preschool , Humans , Infant , Middle Aged , Neurons/metabolism , Signal Transduction/physiology , Young Adult
7.
Clin Genet ; 88(3): 241-7, 2015 Sep.
Article in English | MEDLINE | ID: mdl-25091978

ABSTRACT

Somatic and germline duplications or activating mutations of AKT3 have been reported in patients with hemimegalencephaly and megalencephaly. We performed array comparative genomic hybridization on brain tissue and blood in 16 consecutive patients with symptomatic epilepsy due to focal or multilobar malformations of cortical development who underwent surgical treatment of epilepsy. One patient with infantile spasms and a dysplastic left frontal lobe harboured a somatic trisomy of the 1q21.1-q44 chromosomal region, encompassing the AKT3 gene, in the dysplastic brain tissue but not in blood and saliva. Histopathology revealed severe cortical dyslamination, a thin cortex in the premotor area with microgyri and microsulci, immature neurons with disoriented dendrites and areas of cortical heterotopia in the sub-cortical white matter. These cytoarchitectural changes are close to those defining type Ib focal cortical dysplasia. Immunohistochemistry in brain specimens showed hyperactivation of the PI3K/AKT/mTOR pathway. These findings indicate that AKT3 upregulation may cause focal malformations of cortical development. There appears to be an etiologic continuum between hemimegalencephaly and focal cortical dysplastic lesions. The extent of brain malformations due to AKT3 upregulation may be related to the embryonic stage when the post-zygotic gene alteration occurs.


Subject(s)
Cerebral Cortex/pathology , Chromosome Duplication , Chromosomes, Human, Pair 1 , Proto-Oncogene Proteins c-akt/genetics , Spasms, Infantile/genetics , Spasms, Infantile/pathology , Child , Comparative Genomic Hybridization , Female , Genetic Association Studies , Humans , Immunohistochemistry , Infant, Newborn , Magnetic Resonance Imaging , Male , Malformations of Cortical Development/genetics , Malformations of Cortical Development/pathology , Microsatellite Repeats , Proto-Oncogene Proteins c-akt/metabolism , Spasms, Infantile/diagnosis
9.
Minerva Ginecol ; 63(5): 465-70, 2011 Oct.
Article in Italian | MEDLINE | ID: mdl-21926955

ABSTRACT

Long-term users of tamoxifen (TMX) are at increased risk for developing endometrial cancer. Early diagnosis is mainly based on transvaginal scan (TVS) and hysteroscopy with endometrial biopsy. Nevertheless, TVS does not provide a definitive diagnosis in most cases, particularly due to its high false-positive rate. In addition TMX related changes, such as "pseudocistic" pattern, affect endoscopic evaluation of the endometrium and biopsy sampling (in particular blind procedures) frequently yields insufficient tissue for diagnosis. The cause of the high inadequacy rate of endometrial biopsies in women on TMX might be related to the increase in endometrial fibrous component. The present case emphasizes the main difficulties in surveillance and early diagnosis of endometrial pathologies in TMX users. Liquid-based endometrial cytology played a determinant role in the diagnostic pathway of this patient. We believe it could be used solely or in association with TVS leading to many advantages in the surveillance of women receiving TMX.


Subject(s)
Adenocarcinoma/chemically induced , Adenocarcinoma/pathology , Antineoplastic Agents, Hormonal/adverse effects , Breast Neoplasms/drug therapy , Cytodiagnosis , Endometrial Neoplasms/chemically induced , Endometrial Neoplasms/pathology , Postmenopause , Tamoxifen/adverse effects , Adenocarcinoma/radiotherapy , Adenocarcinoma/surgery , Aged , Antineoplastic Agents, Hormonal/administration & dosage , Biopsy , Cytodiagnosis/methods , Diagnosis, Differential , Early Detection of Cancer , Endometrial Neoplasms/radiotherapy , Endometrial Neoplasms/surgery , Female , Follow-Up Studies , Humans , Hysterectomy , Hysteroscopy/methods , Mastectomy , Predictive Value of Tests , Radiotherapy, Adjuvant , Risk Assessment , Risk Factors , Sensitivity and Specificity , Tamoxifen/administration & dosage , Treatment Outcome
10.
Pathologica ; 103(1): 11-3, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21837919

ABSTRACT

Amniotic band syndrome is an uncommon congenital pathological condition that may lead to malformations and foetal-infant death. We report an autoptic case. The patient was a male preterm infant. At 14 weeks of gestation, a routine ultrasonography showed severe craniofacial anomalies and a close contiguity of the foetal head with the amnios. The neonate survived three days, after which an autopsy was carried out. The infant had a frontoparietal meningoencephalocele; a fibrous band was attached to the skin, close to the meningoencephalocele base. Cleft lip and palate, nose deformation and agenesis of the right eye were also present. At the opening of the cranial cavity, occipital hyperostosis was observed. The herniated brain showed anatomical abnormalities that made identification of normal structures difficult. Microscopically, the nervous parenchyma had architectural disorganization and immaturity, and the fibrous band consisted of amniotic membranes. As evident from this case report, amniotic band syndrome may cause severe malformations and foetal-infant death.


Subject(s)
Amniotic Band Syndrome/diagnosis , Amniotic Band Syndrome/pathology , Autopsy , Cleft Palate/diagnosis , Cleft Palate/pathology , Encephalocele/diagnosis , Encephalocele/pathology , Eye Abnormalities/diagnosis , Eye Abnormalities/pathology , Humans , Infant, Newborn , Male , Nose/abnormalities
11.
Pathologica ; 101(2): 80-4, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19886553

ABSTRACT

Several diagnostic procedures are available to investigate the endometrium, i.e. sonography, hysteroscopy, biopsy, endometrial curettage and cytology. Among these, endometrial cytology is less commonly utilized. Although the use of cytology in the diagnosis of endometrial adenocarcinoma has already been proposed due to its low cost and simple execution, a general consensus has not been reached. The improvement of the diagnostic capacity of endometrial cytology following the introduction of a liquid-based method suggests that this test should be routinely used in endometrial diagnosis. The main advantages of this method are the reduction in confounding factors, the distribution of cells on a thin layer and the possibility to obtain more slides from the same sample. The aim of this article is to focus on the methodological procedures and diagnostic criteria in liquid-based endometrial cytology based on the experience in two Italian centres: Department of Pathology, University of Bari and Department of Human Pathology and Oncology, University of Florence. The sampling method used by the Bari authors consists in the collection of liquid for uterine distension during hysteroscopy, while the Florence group used an endometrial brush. The sensitivity and specificity at Bari were 75% and 83%, respectively, and were 94-100% and 95-100% at Florence, respectively. Endometrial cytology provided sufficient diagnostic material significantly more often than biopsy. We thus propose that endometrial cytology can be used in routine diagnosis either alone or in association with other diagnostic procedures in order to improve diagnostic accuracy.


Subject(s)
Cytological Techniques/methods , Endometrium/pathology , Uterine Diseases/diagnosis , Female , Humans , Italy , Sensitivity and Specificity
12.
Pathologica ; 101(6): 227-9, 2009 Dec.
Article in English | MEDLINE | ID: mdl-20387708

ABSTRACT

Gestational diabetes insipidus (GDI) refers to the state of excessive water intake and hypotonic polyuria. Those cases manifesting in pregnancy and referred to as GDI may persist thereafter or may be a transient latent form that resolves after delivery. Microscopic examination of affected subjects has not been previously reported. In the literature, there are various case reports and case series on diabetes insipidus in pregnancy. In this study, we present a case that had transient diabetes insipidus during pregnancy in which the placenta was examined.


Subject(s)
Diabetes Insipidus/pathology , Placenta/pathology , Pregnancy Complications/pathology , Adult , Diabetes Insipidus/physiopathology , Female , Humans , Pregnancy , Pregnancy Complications/physiopathology
13.
J Chemother ; 20(2): 263-8, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18467255

ABSTRACT

Ependymomas are the third most common brain tumor in children. The post surgical management is controversial. There are no convincing data on an effective role for chemotherapy. O(6)-Methylguanine-DNA-Methyltransferase (MGMT) is a DNA repair protein considered to be a chemosensitivity predictor. Hypermethylation of the MGMT gene promoter is an important cause of MGMT inactivation. We evaluated the MGMT gene promoter methylation and the immunohistochemical MGMT protein expression in 12 recurrent anaplastic ependymomas affecting children. Our purpose was to investigate the molecular rationale of the administration of alkylating agents to children affected by recurrent anaplastic ependymomas. All ependymomas lacked MGMT promoter hypermethylation and 9 (75%) showed high MGMT protein expression (>50% tumoral cells). Differences between different recurrences in the same patient were not observed. These results may indicate MGMT as a factor of chemoresistance to alkylating drugs in anaplastic ependymomas and support the uncertainties regarding the actual benefit of chemotherapy for patients with anaplastic ependymomas.


Subject(s)
Brain Neoplasms/enzymology , DNA Modification Methylases/biosynthesis , DNA Repair Enzymes/biosynthesis , Ependymoma/enzymology , Neoplasm Recurrence, Local/enzymology , Tumor Suppressor Proteins/biosynthesis , Adolescent , Anaplasia , Brain Neoplasms/pathology , Child , Child, Preschool , DNA Methylation , DNA Modification Methylases/genetics , DNA Repair Enzymes/genetics , Drug Resistance, Neoplasm , Ependymoma/pathology , Female , Humans , Immunohistochemistry , Male , Neoplasm Recurrence, Local/pathology , Polymerase Chain Reaction , Promoter Regions, Genetic , Tumor Suppressor Proteins/genetics
14.
Spinal Cord ; 46(10): 703-6, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18283292

ABSTRACT

STUDY DESIGN: A case of a very rare type of schwannoma is reported. It is the sixth reported case of intramedullary melanotic schwannoma and the only one localized in the conus. METHODS: A 56-year-old woman was treated in this department for a C5-C6 spondylodiscitis. After 6 months her arms showed a rapid recovery, but her incomplete flaccid paraplegia remained stable. Magnetic resonance imaging (MRI) with gadolinium enhancement of the lumbar tract revealed an intramedullary lesion at the level of Th12-L1. During surgery, an intramedullary, poorly vascularized, dark gray lesion was detected and was totally removed. One year after surgery, no recurrence was encountered and the patient showed significant improvement. CONCLUSION: It had previously been hypothesized that intramedullary melanotic schwannomas originate from the rostral components of the neural tube. This case presented a different localization with respect to the previously described cases, all localized in the cervical or high thoracic tracts, and thus uncertainties are raised about the previous hypotheses. Nevertheless, it is agreed that total surgical removal is the best treatment.


Subject(s)
Neurilemmoma , Spinal Cord Neoplasms , Female , Humans , Magnetic Resonance Imaging , Middle Aged , Neurilemmoma/pathology , Neurilemmoma/surgery , Spinal Cord Neoplasms/pathology , Spinal Cord Neoplasms/surgery
15.
Pathologica ; 100(6): 451-3, 2008 Dec.
Article in English | MEDLINE | ID: mdl-19475885

ABSTRACT

Acute renal failure occurring in pregnancy or postpartum is often associated with preeclampsia, HELLP syndrome or haemolytic uremic syndrome: differential diagnosis may be difficult due to the overlapping symptoms of these syndromes. We report our experience on diagnosis, management and outcome of women with pregnancy associated haemolytic uremic syndrome, focusing on placental features.


Subject(s)
Acute Kidney Injury/etiology , Diagnostic Errors , Hemolytic-Uremic Syndrome/pathology , Placenta/pathology , Pregnancy Complications, Hematologic/pathology , Adult , Antihypertensive Agents/therapeutic use , Cesarean Section , Combined Modality Therapy , Diagnosis, Differential , Erythrocytes, Abnormal , Female , Glucocorticoids/therapeutic use , HELLP Syndrome/diagnosis , Hemolytic-Uremic Syndrome/blood , Hemolytic-Uremic Syndrome/complications , Hemolytic-Uremic Syndrome/diagnosis , Hemolytic-Uremic Syndrome/therapy , Humans , Infant, Newborn , Infarction/etiology , Infarction/pathology , Placenta/blood supply , Plasma , Pre-Eclampsia/diagnosis , Pregnancy , Pregnancy Complications, Hematologic/blood , Pregnancy Complications, Hematologic/diagnosis , Pregnancy Complications, Hematologic/therapy , Young Adult
16.
Int J Gynecol Cancer ; 18(2): 306-11, 2008.
Article in English | MEDLINE | ID: mdl-17624992

ABSTRACT

The proper management of endometrial polyps still represents a clinical ongoing challenge, especially when they are asymptomatic and occasionally discovered. The aim of this study was to evaluate liquid-based endometrial cytology to manage endometrial polyps in postmenopausal age by its ability to exclude hidden premalignant and malignant changes within polyps. Three hundred fifty-nine consecutive postmenopausal patients who underwent hysteroscopic diagnosis of endometrial polyp over a 3-year period and who were scheduled for surgical removal within the three subsequent months were retrospectively evaluated. Histologic results after resection during operative hysteroscopy or during hysterectomy were compared with liquid-based cytology and endometrial biopsy obtained at the time of diagnostic hysteroscopy. Eight of 359 patients (2.2%) had malignant or premalignant polyps interpreted as benign finding at hysteroscopy. Unsatisfactory samples were higher for endometrial biopsy compared to liquid-based cytology in the whole series and in the subgroup of low-risk asymptomatic patients (P < 0.001). Endometrial biopsy and liquid-based cytology revealed a sensitivity of 62% and 87.5%, respectively and a 100% specificity. Considering the subgroup of low-risk asymptomatic patients, liquid-based cytology disclosed all the five pathologic lesions with a 100% sensitivity and specificity. In conclusion, liquid-based cytology proved to be a useful tool to establish the nature of endometrial polyps in postmenopausal patients. Complete removal of the lesion should be offered to all symptomatic patients and those with established risk factors for endometrial cancer. Conversely, a wait and see attitude should be considered in case of asymptomatic low-risk polyps with typical appearance on hysteroscopy and negative liquid-based cytology.


Subject(s)
Polyps/pathology , Uterine Diseases/pathology , Aged , Aged, 80 and over , Biopsy , Cytodiagnosis , Female , Humans , Hysteroscopy , Middle Aged , Polyps/diagnosis , Polyps/surgery , Postmenopause , Retrospective Studies , Uterine Diseases/diagnosis , Uterine Diseases/surgery
17.
Clin Neuropathol ; 27(6): 373-7, 2008.
Article in English | MEDLINE | ID: mdl-19130733

ABSTRACT

Pilomyxoid astrocytoma is a recently described tumor. Its most typical morphological characteristics are an angiocentric astrocytic proliferation embedded in a myxoid background. The behavior seems to be unfavorable due to the reported high rate of local recurrence. The earlier studies indicated that pilomyxoid astrocytoma typically affects young children and arises in the hypothalamic/chiasmatic region. We report a case of a 14-year-old patient with a 6-year history of absence seizure. Magnetic resonance imaging showed a right occipital lesion of approximately 3 cm in diameter. The patient underwent the surgical procedure with gross total excision. Histologically, the tumor was mainly composed of a monomorphous population of bipolar elongated piloid cells radially arranged around thin-walled blood vessels in a prominent myxoid background. There were focal hemorrhagic foci but no bona fide evidence of tumor necrosis or mitoses. Rosenthal fibers and eosinophilic granular bodies were not observed. The postoperative course was uneventful. No adjuvant therapy was administered. The patient is alive and well at 18-month follow-up. The case presented provides evidence that pilomyxoid astrocytoma can occur at a later age and can arise in regions different from hypothalamic/chiasmatic.


Subject(s)
Astrocytoma/diagnosis , Brain Neoplasms/diagnosis , Occipital Lobe , Adolescent , Astrocytoma/surgery , Brain Neoplasms/surgery , Female , Humans
18.
Acta Neurochir (Wien) ; 149(8): 799-803; discussion 803, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17660939

ABSTRACT

Tumour-to-tumour metastasis is a rare pathological entity. Meningioma is the most common intracranial tumour to host metastases, the majority of which arise from breast and lung cancers. We present the first report of a colonic cancer metastasis within an intracranial meningioma.A 76-year-old woman presented with a one month history of partial seizures. Her medical history included resection of an adenocarcinoma of the descending colon followed by adjuvant chemotherapy 1 year before our evaluation. Magnetic resonance imaging revealed a homogeneously enhancing lesion in the right frontal convexity.A well capsulated tumour attached to the frontal dura was surgically removed. The pathological examination demonstrated a mixture of fibrous meningioma and colloid adenocarcinoma. Possible explanations for the development of a cohesive chimeric mass of composite pathology are investigated.


Subject(s)
Adenocarcinoma/secondary , Adenocarcinoma/surgery , Colonic Neoplasms/surgery , Meningeal Neoplasms/secondary , Meningeal Neoplasms/surgery , Meningioma/surgery , Neoplasms, Second Primary/surgery , Adenocarcinoma/diagnosis , Adenocarcinoma/pathology , Aged , Colectomy , Colonic Neoplasms/diagnosis , Colonic Neoplasms/pathology , Craniotomy , Female , Humans , Magnetic Resonance Imaging , Meningeal Neoplasms/diagnosis , Meningeal Neoplasms/pathology , Meningioma/diagnosis , Meningioma/pathology , Neoplasms, Second Primary/diagnosis , Neoplasms, Second Primary/pathology , Postoperative Complications/diagnosis , Postoperative Complications/pathology , Postoperative Complications/surgery , Reoperation
19.
Cytopathology ; 18(4): 241-9, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17559564

ABSTRACT

OBJECTIVE: Liquid-based cytology, because of its capacity to reduce the obscuring factors and to provide thin-layer specimens, represents an opportunity to reevaluate endometrial cytology. In order to assess the utility of the liquid-based method in endometrial diagnosis, we evaluated its accuracy in comparison with histology. METHODS: Nine hundred and seventeen women scheduled for hysteroscopy were enrolled in the study. After providing informed consent, all the women proceeded sequentially to hysteroscopy, endometrial cytology and then biopsy endometrial sampling. RESULTS: Cyto-histological correlations were possible in 519 cases (57%): in 361 (39%) cases the biopsy was inadequate, in 15 (2%) the cytology was inadequate, and in 22 (2%) both were inadequate. At biopsy 25 (3%) women had adenocarcinoma, 5 (1%) had adenomatous atypical hyperplasia and 21 (2%) had simple non atypical hyperplasia. At cytology two adenocarcinomas and one adenomatous atypical hyperplasia were underrated as atypical hyperplasias and as non-atypical hyperplasia; two simple non-atypical hyperplasias were reported as negative; and eight cases were false positive (non-atypical hyperplasia at cytology, negative at biopsy). In our population, the cytology provided sufficient material more often than biopsy (P < 0.04). Sensitivity was estimated at 96%, specificity at 98%, positive predictive value at 86% and negative predictive value at 99%. CONCLUSIONS: We concluded that endometrial cytology may be an efficient diagnostic method. It could be applied to selected patients solely or in association with ultrasonography. The combination of these two noninvasive procedures may improve their diagnostic accuracy and reduce unnecessary hysteroscopies, thereby producing benefits for women and society.


Subject(s)
Endometrial Neoplasms/diagnosis , Endometrium/pathology , Adult , Aged , Aged, 80 and over , Biopsy/methods , Carcinoma, Endometrioid/diagnosis , Carcinoma, Endometrioid/pathology , Cytodiagnosis/methods , Endometrial Hyperplasia/diagnosis , Endometrial Hyperplasia/pathology , Endometrial Neoplasms/pathology , Female , Humans , Hysteroscopy , Middle Aged , Predictive Value of Tests , Sensitivity and Specificity , Specimen Handling/methods
20.
Int J Gynecol Cancer ; 17(1): 182-7, 2007.
Article in English | MEDLINE | ID: mdl-17291251

ABSTRACT

The incidence of endometrial adenocarcinoma in asymptomatic women is low. Nevertheless, some of these women might require endometrial surveillance. In this study, we evaluated the accuracy of liquid-based endometrial cytology compared to biopsy in asymptomatic postmenopausal women. Three hundred twenty women scheduled for hysteroscopy were enrolled for this study. After hysteroscopy, patients were submitted to endometrial cytology and to biopsy. Two hundred ninety-three (92%) women had sonographically thickened endometrium (>5 mm), 53 (17%) were on tamoxifen, and 16 (5%) were on hormonal substitutive treatment. The evaluation of the biopsies determined that six (2%) women had adenocarcinoma, one (<1%) had adenomatous atypical hyperplasia, and eight (3%) had simple nonatypical hyperplasia. Endometrial cytology evidenced 5 (2%) neoplastic cases, 2 (<1%) hyperplastic with atypia cases, and 25 (8%) hyperplastic without atypia cases. Two hundred twenty-two biopsies (69%) and 17 (5%) cytologies were inadequate. One adenocarcinoma and one simple nonatypical hyperplasia were underrated by cytology resulting, respectively, as atypical hyperplasia and as negative. Four cases were false positive (simple nonatypical hyperplasias on cytology, negative on biopsy). The sensitivity and specificity were estimated, respectively, at 94% and 95%; the positive and negative predictive value were estimated, respectively, at 80% and 99%. Endometrial cytology provided sufficient material more often than biopsy (P < 0.01). We suggest to introduce liquid-based endometrial cytology in the management of some subpopulations of asymptomatic postmenopausal women. Particularly, the combination of liquid-based endometrial cytology and transvaginal sonography may improve their diagnostic accuracy and reduce unnecessary more invasive and expensive procedures.


Subject(s)
Adenocarcinoma/pathology , Cytodiagnosis/methods , Endometrial Neoplasms/pathology , Endometrium/pathology , Postmenopause , Aged , Aged, 80 and over , Biopsy , Female , Humans , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...